To summarize, the data demonstrated that TrkC enhances the metastatic potential of ES by inhibiting the proteasomal degradation of EWSR1-FLI1 via the formation of a TrkC/EWSR1-FLI1 complex. The gene discussed is EWSR1; the disease is Ewing sarcoma.